comparemela.com

Latest Breaking News On - Pharmaseed ltd - Page 1 : comparemela.com

MIRA Pharmaceuticals in Discussions with Memorial Sloan Kettering to Collaborate on Preclinical Cancer Pain Model Utilizing The Company s Novel Oral Ketamine Analog

Ketamir-2, the Company s novel oral ketamine analog in development, aims to provide a safe and effective alternative for managing cancer pain and associated depression MIAMI, May 21, 2024.

United statesErez aminovAmitabh gulatiItzchak angelSloan ketteringPharmaceuticals incSecurities exchangeBoard member of cancer pain research consortiumNational cancer instituteSloan kettering cancer centerPharmaceuticals in discussionsDrug administrationPharmaseed ltdSloan kettering instituteMemorial sloan kettering cancer centerUs drug enforcement administration

Mira Pharmaceuticals Advances Preclinical Trials T

MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) ("MIRA" or the "Company"), a pre-clinical-stage pharmaceutical company focused on the treatment of neurologic and

United statesItzchak angelErez aminovScientific advisor of mira pharmaceuticalsTraumatic stress disorder treatment market researchPharmaseed ltdUs drug enforcement administrationNational institutes of healthMira pharmaceuticals advances preclinical trialsMarket researchPharmaceuticals incBiotrial incAmira pharmaceuticalsDrug administrationInvestigational new drug applicationPreclinical trials

vimarsana © 2020. All Rights Reserved.